Breaking News

You are here » Indian-Commodity  :  Corporate  :  Indo Amines to raise Term Loan of Rs 6.8 crore for Baroda Capex project

06-Aug2016

Indo Amines to raise Term Loan of Rs 6.8 crore for Baroda Capex project

Indo Amines has received an approval to raise Term Loan of Rs 6.8 crore for Baroda Capex project. The board of director at its meeting held on August 05, 2016 has approved for the same.

In July, the company had acquired 100% stake in Classic Oil pursuant to which Classic Oil had became wholly owned subsidiary of the company.

Indo Amines manufactures various types of fatty amines, amine derivatives that are used by various industries for direct application. Its products also have specialized process application for various industries and their processes. 



Related News

View all news

MRF's workers call strike at Tiruvottiyur plant

MRF's workers are on strike at manufacturing plant at Tiruvottiyur near Chennai, since February 2. The strike is illegal and the notice of the strike, including reasons for the same, has not been served......

Linde India reports 62% rise in Q4 net profit

Linde India has reported results for fourth quarter ended December 31, 2018. The company has reported a rise of 61.97% in its net profit at Rs 15.42 crore for the quarter under review as compared to Rs......

Valecha Engineering reports net loss of Rs 15.98 in Q3

Valecha Engineering has reported results for third quarter ended December 31, 2018. The company has reported a net loss of Rs 15.98 crore for the quarter as compared to net loss of Rs 13.19 crore for the......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......